ImmunoPrecise Antibodies Ltd. (HYFT)
Market Closed
3 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 35
+0.06
+4.6512%
Pre Market
$
+0.05 +3.7037% 1. 40
60.61M Market Cap
- P/E Ratio
- Div Yield
136,071 Volume
- Eps
$ 1.29
Previous Close Investors:
Want to track HYFT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmunoPrecise Antibodies Ltd. (HYFT) Statistics
Valuation metrics
Market Cap 60.61M
Enterprise value 77.16M
Trailing P/E (ttm) -5.93
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 5.5
Price/Book (mrq) 7.2
Enterprise Value/Revenue 4.99
Enterprise Value/EBITDA -5.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 178.6K
Average volume (90 days) 399.32K
Price summary
52-Week low 0.99
52-Week high 3.25
Beta -
50-Day moving average 1.47
200-Day moving average 1.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 23 Nov 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.9%
Operating margin -0.96%
Operational effectiveness
Return on assets -0.65%
Return on equity -0.91%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.24
Total debt (mrq) -
Total Debt/Equity (mrq) 0.3
Current ratio (mrq) 2.8%
Book value per share (mrq) 0.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
